HBIO vs LCTC: stock comparison and AI forecast
Harvard Bioscience Inc (HBIO) and Lifeloc Technologies, Inc (LCTC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
HBIO Harvard Bioscience Inc
- Price
- $8.46 +24.6% · 6M
- Market Cap
- $39M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
LCTC Lifeloc Technologies, Inc
- Price
- $3.25 +58.5% · 6M
- Market Cap
- $9M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- HBIO is 4.3 times larger than LCTC by market capitalization ($39M against $9M).
- Over the last six months LCTC returned +58.5% and HBIO +24.6%.
- HBIO carries 9.28 times debt per unit of equity, against 0.85 times for LCTC.
- Both companies share the SEC industry classification Laboratory Analytical Instruments.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | HBIO | LCTC |
|---|---|---|
| Market Cap | $39M | $9M |
| P/B Ratio | 5.19x | 2.34x |
| EPS | $-12.94 | $-0.81 |
| Book Value/Share | $1.63 | $1.39 |
| Revenue/Share | $19.29 | $3.37 |
| FCF/Share | $-0.25 | $-0.30 |
Profitability & Margins
| Metric | HBIO | LCTC |
|---|---|---|
| ROE | – | -54.3% |
| ROA | – | -29.3% |
| ROIC | -0.5% | -13.4% |
| Gross Margin | 58.2% | 42.0% |
| Operating Margin | -0.3% | -8.7% |
| Net Margin | – | -22.3% |
| EBT Margin | -12.0% | -8.4% |
| Tax Rate | 1.2% | -149.5% |
Financial Health
| Metric | HBIO | LCTC |
|---|---|---|
| Current Ratio | 1.87x | 4.35x |
| Quick Ratio | 0.98x | 1.76x |
| D/E Ratio | 9.28x | 0.85x |
| Financial Leverage | 10.28x | 1.85x |
| Interest Coverage | -0.8x | -3.7x |
| Working Capital | $22M | $4M |
Cash Flow
| Metric | HBIO | LCTC |
|---|---|---|
| Operating Cash Flow | $650K | -$370K |
| Free Cash Flow | -$1M | -$820K |
| Capital Spending | -$2M | -$450K |
| OCF Growth YoY | -90.2% | – |
| FCF Growth YoY | -123.1% | – |
| FCF/Sales | -1.3% | -8.8% |
| CapEx/Sales | 2.0% | 4.8% |
Operational Efficiency
| Metric | HBIO | LCTC |
|---|---|---|
| Asset Turnover | 1.15x | 1.31x |
| Receivables Turnover | 6.1x | 11.2x |
| Inventory Turnover | 1.6x | 1.9x |
| Fixed Assets Turnover | 16.4x | 4.2x |
| Days Sales Outstanding | 60 days | 33 days |
| Days Inventory | 221 days | 193 days |
| Payables Period | 62 days | 34 days |
| Cash Conversion Cycle | 219 days | 191 days |
Income Statement
| Metric | HBIO | LCTC |
|---|---|---|
| Total Revenue | $88M | $9M |
| Operating Income | -$240K | -$800K |
| Net Income | – | -$2M |
| R&D Expense | $9M | $2M |
| SG&A Expense | $40M | – |
| Cost of Goods Sold | $37M | $5M |
Dividend & Shareholder Information
| Metric | HBIO | LCTC |
|---|---|---|
| Shares Outstanding | 5M | 3M |
HBIO vs LCTC: stock comparison and AI forecast
Which is bigger, HBIO or LCTC?
HBIO is 4.3 times larger than LCTC by market capitalization ($39M against $9M).
Which stock performed better over the last six months, HBIO or LCTC?
Over the last six months LCTC returned +58.5% and HBIO +24.6%.
Which one does Intratio's AI model rank higher, HBIO or LCTC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.